Search
for
Sort by
Research 121–150 of 353
- Psychoactive drugs and skin
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Integrating Psychodermatology and Platelet-Rich Plasma Therapy in Various Dermatological Conditions: A Narrative Review
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Effects of local and systemic medications on eye health: Adverse reactions
- The Role of Hormonal Imbalances in Amenorrhea
- Psychodermatology U.K.
- Clinical aspects of the metabolic syndrome
- Differential Diagnosis of Male and Female Pattern Hair Loss
- AVALIAÇÃO DO USO DE TELAS DIGITAIS POR CRIANÇAS E ADOLESCENTES EM TEMPOS DE PANDEMIA
- Dermatologists’ Role in Interdisciplinary Care for Obsessive-Compulsive Disorder and Body-Focused Repetitive Behaviors
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Med Check
- Venlafaxine induced hair loss: a case report
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Role of Phenylalanine and Its Metabolites in Health and Neurological Disorders
- Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens
- HHV-6 reactivations in immunocompetent patients with psychiatric disorders: visual hallucinations or possible interactions?
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice
- Management of psychiatric disorders with HIV and dermatological disorders